TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

AstraZeneca to cut 1,600 in U.S., U.K.

AZN $46.18 -$0.28

at close on MONDAY

By The Associated Press
Tuesday, March 19, 2013, 12:01 a.m.
 

Struggling Anglo-Swedish drugmaker AstraZeneca PLC said Monday that it will eliminate 1,600 jobs, mostly in the United States and United Kingdom, as its new CEO starts a major research and development reorganization.

The cuts come just weeks after the company reported big drops in revenue and net income for 2012 and forecast continuing difficulties as generic competition hurts sales.

The job reductions amount to nearly 3 percent of AstraZeneca's 57,200 workers.

worldwide and are part of moves affecting several major AstraZeneca sites in the UK, US and Sweden.

Even the global headquarters will be shifted, from London to Cambridge, England, as the company moves many of its scientists near top centers for bioscience research. Rivals have been doing the same, to be near those talent pools and to increase collaborations with scientists at universities and small biotech companies.

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. U-PARC houses companies ranging from innovative to traditional
  2. Dominion, Duke to build $5B natural gas pipeline from WV to NC
  3. Visual search  still hampered  by image issues
  4. Gas drilling company withdraws application for forced pooling in Western Pennsylvania
  5. Government approves compromise on Corbett’s alternative Medicaid plan
  6. Healthy PA expands number of recipients but cuts benefits
  7. Lower your cable bill by streaming shows
  8. Young adults drive home rental trend in Western Pennsylvania
  9. Students walk shop class path to excellence
  10. States clear way for startups to use crowdfunding
  11. 2 top technology officers leave UPMC
Subscribe today! Click here for our subscription offers.